Xiaoyan Michelle Zhang - 10 Dec 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role: Chief Scientific Officer
Signature: /s/ Douglas R. Carlson, as Attorney-in-Fact for Xiaoyan Michelle Zhang
Issuer symbol: IKNA
Transactions as of: 10 Dec 2021
Net transactions value: -$12,614
Form type: 4
Filing time: 14 Dec 2021, 19:48:34 UTC
Previous filing: 23 Nov 2021
Next filing: 12 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IKNA	Common Stock	Options Exercise	$2,146	+1,000	+2.2%	$2.15	45,475	10 Dec 2021	Direct
transaction	IKNA	Common Stock	Sale	$14,760	-1,000	-2.2%	$14.76	44,475	10 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IKNA	Stock Option (Right to Buy)	Options Exercise	$0	-1,000	-3.8%	$0.000000	25,473	10 Dec 2021	Common Stock	1,000	$2.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.